申请人:AbbVie Inc.
公开号:US08669255B2
公开(公告)日:2014-03-11
The present application relates to: (a) compounds of Formula (I):
and salts thereof, wherein Z1, Z2, Z3, Z4, R1, R2, and R3 are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, salts, and compositions, particularly use as calcium channel inhibitors.
本申请涉及以下内容:(a) 公式(I)的化合物及其盐,其中Z1、Z2、Z3、Z4、R1、R2和R3的定义如规范所述;(b) 包含这些化合物和盐的组合物;以及(c) 使用这些化合物、盐和组合物的方法,特别是作为钙通道抑制剂的用途。